PERI-Pause
PERI-Pause, licence 80031417: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Nutra Pause
- Licence holder
- AC NOVA TECHNOLOGIES INC.
- NPN or DIN-HM
- 80031417
- Status
- Active licence
- Licence date
- 13 April 2012
- Revision date
- 18 March 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Eucommia ulmoides Source : Écorce âgée Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Rouge FD&C no 40, Hypromellose, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Botanical supplement that supports the management of symptoms and discomfort commonly associated with peri menopause or menopause. A healthy combination of botanical extracts derived from Mung Beans and Eucommia bark. Clinically shown to relieve hot flashes or nights sweats in women experiencing at least 3 hot flashes or night sweats per day. The combination of Eucommia and Mung Bean extract used in PeriPause has been shown in a controlled clinical study to significantly reduce the number/frequency of hot flashes and night sweats (vasomotor symptoms).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031417
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.